New Jersey And New York Doctors, 20 Others Charged In Oxycodone Distribution Conspiracy
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • New Jersey And New York Doctors, 20 Others Charged In Oxycodone Distribution Conspiracy

New Jersey And New York Doctors, 20 Others Charged In Oxycodone Distribution Conspiracy

May 11, 2011
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

TRENTON, N.J. - Brian R. Crowell, the Special Agent in Charge of the New Jersey Division of the Drug Enforcement (DEA) and Paul J. Fishman, the United States Attorney for the District of New Jersey, announced two physicians who allegedly wrote illegal prescriptions for oxycodone were arrested this morning, along with a number of others, on federal charges that they participated in a conspiracy to illegally distribute the medication.

Dr. Jacqueline Lopresti, 50, of Fair Haven, N.J., and Dr. Hassan Lahham, 53, of New York, are charged in a federal criminal Complaint along with 20 other defendants with conspiracy to possess and distribute oxycodone. One of those co-defendants, Christopher Erwin, 47, of Barnegat, N.J., is a purported landscaper who served as leader of the drug trafficking organization.

Of the 22 defendants charged, 16 were arrested this morning by members of the DEA’s Tactical Diversion Squad. The defendants arrested today are expected to appear this afternoon before U.S. Magistrate Judge Tonianne J. Bongiovanni in Trenton federal court. All the charged defendants are identified in a chart appended to this release.

According to the Complaints unsealed today:

Oxycodone, the active ingredient in brand name pills such as Oxycontin, Roxicodone and Percocet, is a Schedule II controlled substance + meaning that it has a high potential for abuse, a currently accepted medical use with severe restrictions, and abuse of the drug may lead to severe psychological or physical dependence.

Since at least as early as January 2009, and continuing for at least two years, Lopresti and Lahham issued prescriptions to co conspirators who received the prescriptions, at the direction of Erwin and others, for drugs containing oxycodone outside the usual course of medical practice and not for any legitimate medical purpose. The prescriptions were filled at various pharmacies located in and around Monmouth, Ocean, and Atlantic Counties, and the defendants then sold and redistributed the pills.

Lopresti and Lahham wrote the prescriptions in exchange for cash payments from Erwin and others, knowing that the pills were to be redistributed.

Erwin and others, with the knowledge of Lopresti and Lathham, employed customers to pose as patients and others to serve as runners to transport customers to fill the prescriptions at numerous pharmacies in an attempt to avoid detection. Erwin and others paid customers and runners either in cash or with a portion of the oxycodone tablets that were obtained from the pharmacies, then sold the remaining tablets at a profit.

U.S. Attorney Fishman stated: “Prescription drug abuse is the fastest growing drug problem in the country. It is particularly troubling to find doctors so complicit in this epidemic. We trust our doctors to heal our bodies, not poison our communities. We can’t and we shouldn’t put up with those we count on for our well being to make a fast buck peddling pills.”

Brian R. Crowell, Special Agent in Charge of the DEA New Jersey Division, stated, “Our commitment to the citizens of New Jersey is to protect them from legal controlled substances which help people daily but may fall into the illicit market for drug traffickers. Let us be perfectly clear: everyone arrested today is an alleged drug trafficker. We will not tolerate or accept this illegal behavior, and we will bring justice to all that condone this type of practice.”

The count with which the defendants are charged carries a maximum potential penalty of 20 years in prison and a $1 million fine.

U.S. Attorney Fishman thanked special agents of the DEA in New Jersey, under the direction of Special Agent in Charge Brian R. Crowell, and the various police departments which have officers assigned to the New Jersey DEA Tactical Diversion Squad. He also thanked the law enforcement partner agencies that effected the arrests, including the U.S. Marshals Service; U.S. Food & Drug Administration; Cumberland, Monmouth, and Ocean County Prosecutor’s Offices; New Jersey State Police; Ocean County Sherriff’s Office; Barnegat, Lacey Township, Little Egg Harbor, Little Silver, Seaside Heights, Toms River, and Trenton Police Departments; and the Ocean County Department of Corrections.

The government is represented by Assistant U.S. Attorney Robert Marasco of the U.S. Attorney’s Office Criminal Division in Trenton.

The charges and allegations contained in the Complaints are merely accusations, and the defendants are considered innocent unless and until proven guilty.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Towanda Thorne-James Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster